# Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients

> **NCT04804514** · PHASE1,PHASE2 · COMPLETED · sponsor: **HysensBio Co., Ltd** · enrollment: 40 (actual)

## Conditions studied

- Dentin Sensitivity

## Interventions

- **DRUG:** KH001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04804514
- **Lead sponsor:** HysensBio Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-14
- **Primary completion:** 2023-03-03
- **Final completion:** 2023-03-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04804514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04804514, "Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04804514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*